Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Parkinson's Disease
Related studies linked through entity extraction aliases.
Use of Noninvasive Brain Stimulation in Parkinson's Disease
- Status
- COMPLETED
- Phase
- NA
Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE4
Imaging Biomarkers of Progression of Mobility Impairment in Parkinson Disease
- Status
- COMPLETED
- Phase
- N/A
Safety, Tolerability and Pharmacokinetic Profile of Levodopa Administered With Continuous Administration of ND0611
- Status
- COMPLETED
- Phase
- PHASE1
Transcranial Direct Current Stimulation (tDCS) and Parkinson's Disease
- Status
- COMPLETED
- Phase
- NA
Deep Brain Stimulation Effects Study
- Status
- TERMINATED
- Phase
- PHASE1
An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Italian Validation of the Revised MDS-Unified Parkinson's Disease Rating Scale
- Status
- UNKNOWN
- Phase
- N/A
Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced Dyskinesia
- Status
- COMPLETED
- Phase
- PHASE2
Cognitive Rehabilitation in Parkinson's Disease
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Nucleipark:High Field MR Imaging (7T and 3T) of the Brainstem, the Deep Nuclei and Their Connections in the Parkinsonian Syndromes. Applications to Prognosis, Pathophysiology and Improvement of Therapeutic Strategies
- Status
- COMPLETED
- Phase
- N/A
Clinical, Molecular and by Neuroimaging of LRRK2 Mutations
- Status
- COMPLETED
- Phase
- N/A
Effect of Deep Brain Stimulation on Gastrointestinal (GI) Motility
- Status
- COMPLETED
- Phase
- NA
rTMS for Motor and Mood Symptoms of Parkinson's Disease
- Status
- COMPLETED
- Phase
- NA
Phase II Subthalamic Nucleus (STN) vs. Globus Pallidus (GPi) Trial
- Status
- COMPLETED
- Phase
- PHASE3
Validation of Dyskinesia Rating Scales
- Status
- COMPLETED
- Phase
- PHASE4
Levodopa Concentration Profile With Stalevo 75/125 mg
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Extended Long-Term Safety Study of KW-6500
- Status
- COMPLETED
- Phase
- PHASE3